FOLD News & Analysis
2 articles
Market Mood
Fold Holdings (FOLD) CTO Thomas Dickman Sells $2 in Shares
Thomas Dickman, the CTO of Fold Holdings (FOLD), sold shares valued at $2. This transaction highlights the movement of insider shares and may raise questions about management's confidence in the company's future. While the amount is small, tracking insider sales can be critical for investors assessing company health. Such sales could signal a variety of insights into the company's performance and management's outlook, which is important for market participants.
Read More: Fold Holdings (FOLD) CTO Thomas Dickman Sells $2 in Shares
CIBRA Capital Acquires 1.48M Shares of Amicus Therapeutics (FOLD)
CIBRA Capital Ltd increased its shareholding in Amicus Therapeutics (FOLD) by 1,476,861 shares, valued at approximately $21.17 million as per the SEC filing on April 24, 2026. The total value of this position rose to $24.40 million, accounting for 11.78% of CIBRA's reportable assets under management. This transaction reflects a 10.2% increase in assets and comes as Amicus shares were priced at $14.46, having achieved a 103.7% total return over the past year. Key products include therapies for rare diseases like Fabry and Pompe, contributing to $634.21 million in revenue.
Read More: CIBRA Capital Acquires 1.48M Shares of Amicus Therapeutics (FOLD)